POTENCY OF LUTEOLIN WITH SOLID LIPID NANOPARTICLE (SLN)-POLYETHYLENE GLYCOL (PEG) MODIFICATION FOR ARTEMISININ-RESISTANT PLASMODIUM FALCIPARUM INFECTION

POTENCY OF LUTEOLIN WITH SOLID LIPID NANOPARTICLE (SLN)-POLYETHYLENE GLYCOL (PEG) MODIFICATION FOR ARTEMISININ-RESISTANT PLASMODIUM FALCIPARUM INFECTION

Falciparum malaria is still considered as one of the important global health problems and its causal agent (Plasmodium falciparum) is reported to be the third most common factor for contributing the number of deaths in the world. As we all know, Artemisinins are the most rapidly acting of currently...

Full description

Bibliographic Details
Main Authors:	William Kamarullah, Erika Indrajaya, Janice Emmanuella
Format:	Article
Language:	English
Published:	Universitas Airlangga 2018-10-01
Series:	Indonesian Journal of Tropical and Infectious Disease
Subjects:	luteolin, plasmodium falciparum, artemisinin resistance, sln, peg
Online Access:	https://e-journal.unair.ac.id/IJTID/article/view/6726

Similar Items

Preparation and Physicochemical Characterization of Biodegradable mPEG-PCL Core-Shell Micelles for Delivery of Artemisinin
by: Hamid Reza Kheiri Manjili 1, Hojjat Malvandi 3, Mir-Sajjad Mosavi 1, Hossein Danafar 2,3 *
Published: (2016-12-01)

Induction of Plasmodium falciparum strain 2300 dormant forms by artemisinin
by: Lilik Maslachah, et al.
Published: (2015-04-01)

Induction of Plasmodium falciparum strain 2300 dormant forms by artemisinin
by: Lilik Maslachah, et al.
Published: (2016-02-01)

Malarial pathogenesis and interventions in Kelch mediated Artemisinin resistance in Plasmodium falciparum
by: Pittala, Keerthana
Published: (2019)

Delivery luteolin with folacin-modified nanoparticle for glioma therapy
by: Wu C, et al.
Published: (2019-09-01)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
by: Amaratunga, C., et al.
Published: (2022)

Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria
by: Dinkorma T. Ouologuem, et al.
Published: (2018-12-01)

New orally active artemisinin dimer antimalarials
by: Mahmoud A ElSohly, et al.
Published: (2017-01-01)

Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
by: Qingyun Huang, et al.
Published: (2010-12-01)

No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti
by: Jeanne P. Vincent, et al.
Published: (2018-11-01)

Profil Fenotipik Plasmodium falciparum Galur Papua 2300 Akibat Paparan Antimalaria Artemisinin in Vitro
by: Lilik Maslachah, et al.
Published: (2015-03-01)

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure
by: Sandie Ménard, et al.
Published: (2015-10-01)

Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009–2013)
by: Myat Htut Nyunt, et al.
Published: (2017-08-01)

Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014–2016
by: Mie Ikeda, et al.
Published: (2018-04-01)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
by: Florian Kurth, et al.
Published: (2016-08-01)

Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy
by: Ogouyèmi-Hounto Aurore, et al.
Published: (2016-01-01)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
by: Angana Mukherjee, et al.
Published: (2017-05-01)

Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated <it>falciparum</it> malaria in calabar, Nigeria
by: Meremikwu Martin M, et al.
Published: (2012-12-01)

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01)

Plasmodium falciparum malarial parasites from Brazil lack artemisinin resistance-associated mutations in the kelch13 gene
by: Francesca Chapadense, et al.
Published: (2019-02-01)

Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
by: Ouji Manel, et al.
Published: (2018-01-01)

Etudes des mécanismes cellulaires et moléculaires de Plasmodium falciparum impliqués dans les résistances aux combinaisons à bases de dérivés de l’artémisinine
by: Duru, Valentine
Published: (2016)

Novel Mutations in K13 Propeller Gene of Artemisinin-Resistant Plasmodium falciparum
by: Rie Isozumi, et al.
Published: (2015-03-01)

High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure
by: Rajeev K. Tyagi, et al.
Published: (2018-10-01)

Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia
by: Ankit Dwivedi, et al.
Published: (2017-12-01)

Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan
by: Najia Karim Ghanchi, et al.
Published: (2021-04-01)

Studies on the mechanisms of action of artemisinins and the role of PfATP6
by: Pulcini, Serena
Published: (2011)

Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives
by: LUIZ C.S. PINHEIRO, et al.

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam
by: Thanh Nguyen, et al.
Published: (2012-06-01)

Efficacy of Artemisinin Base Combination Therapy and Genet-ic Diversity of Plasmodium falciparum from Uncomplicated Malaria Falciparum Patient in District of Pesawaran, Province of Lampung, Indonesia
by: Jhons Fatriyadi SUWANDI, et al.
Published: (2019-03-01)

Post-artemisinin delayed hemolysis after oral therapy for P. falciparum infection
by: Christian C. Conlon, et al.
Published: (2020-01-01)

Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance
by: Matthew J. Grigg, et al.
Published: (2018-12-01)

Artemisinin resistance in <it>Plasmodium falciparum </it>is associated with an altered temporal pattern of transcription
by: Newton Paul N, et al.
Published: (2011-08-01)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
by: Almahamoudou Mahamar, et al.
Published: (2021-01-01)

Detection of point mutation in Plasmodium falciparum ATPase6 gene associated with artemisinin resistance from Assam and Arunachal Pradesh
by: Jitendra Sharma, et al.
Published: (2014-12-01)

The efficacy and safety of artemisinin-based combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in non-pregnant adults and children : a systematic review.
by: Zani, Babalwa.
Published: (2013)

Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand–Myanmar Border
by: Mikael Boullé, et al.
Published: (2016-08-01)

Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence
by: Khalid Rehman, et al.
Published: (2014-12-01)

Genomic epidemiology of artemisinin resistant malaria
by: MalariaGEN Plasmodium falciparum Community Project
Published: (2016-03-01)

Widespread Availability of Artemisinin Monotherapy in the United States
by: Robert M. Rakita, et al.
Published: (2011-05-01)